Cargando…
Proof of SARS-CoV-2 genomes in endomyocardial biopsy with latency after acute infection
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has reached pandemic levels. Cardiovascular complications in COVID-19 have been reported frequently, however evidence for a causal relationship has not been esta...
Autores principales: | Pietsch, Heiko, Escher, Felicitas, Aleshcheva, Ganna, Baumeier, Christian, Morawietz, Lars, Elsaesser, Albrecht, Schultheiss, Heinz-Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546659/ https://www.ncbi.nlm.nih.gov/pubmed/33045427 http://dx.doi.org/10.1016/j.ijid.2020.10.012 |
Ejemplares similares
-
Detection of viral SARS‐CoV‐2 genomes and histopathological changes in endomyocardial biopsies
por: Escher, Felicitas, et al.
Publicado: (2020) -
Advancing Precision Medicine in Myocarditis: Current Status and Future Perspectives in Endomyocardial Biopsy-Based Diagnostics and Therapeutic Approaches
por: Baumeier, Christian, et al.
Publicado: (2023) -
Detection of parvovirus mRNAs as markers for viral activity in endomyocardial biopsy-based diagnosis of patients with unexplained heart failure
por: Pietsch, Heiko, et al.
Publicado: (2020) -
Plasminogen activator inhibitor-1 reduces cardiac fibrosis and promotes M2 macrophage polarization in inflammatory cardiomyopathy
por: Baumeier, Christian, et al.
Publicado: (2021) -
Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2021)